Provided by Tiger Fintech (Singapore) Pte. Ltd.

CASI Pharmaceuticals

1.95
+0.0000
Volume:296.00
Turnover:581.53
Market Cap:30.21M
PE:-0.76
High:1.95
Open:1.95
Low:1.95
Close:1.95
Loading ...
Aug 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 09, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 19, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Jun 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Major Issues Report

Current report, items 5.02, 5.07, and 9.01
Jun 18, 2019

Major Issues Report

Current report, items 1.01 and 9.01
May 15, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 15, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Apr 11, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Nov 27, 2018

Correspondence

[Cover]Correspondence
Nov 14, 2018

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Oct 24, 2018

Major Issues Report

[Amend] Current report, items 5.02 and 9.01
Aug 06, 2018

Correspondence

[Cover]Correspondence
May 14, 2018

Beneficial Ownership Change